Update: 12.10.2022
Last week: 38 week 2022 (26.09.2022 - 02.10.2022)
Last full month: Sep 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 190 506 | -8.5% | 3.7% | -0.1 | 39 791 466 | -8.8% | 3.7% | -0.1 | -6.8% |
| MoM | 747 528 | 79.1% | 3.7% | 0 | 153 590 034 | 85.1% | 3.8% | 0.1 | 81.0% |
| YTD | 7 729 546 | -6.0% | 5.5% | -0.6 | 1 533 868 436 | 10.9% | 5.2% | -0.2 | 4.9% |
| MAT | 12 779 716 | 15.3% | 6.0% | 0.5 | 2 441 157 988 | 34.0% | 5.6% | 0.7 | 5.3% |
| DEXALGIN | |||||||||
| WoW | 22 754 | -15.7% | 0.4% | -0.1 | 10 944 063 | -15.8% | 1.2% | -0.1 | -2.5% |
| MoM | 90 811 | 16.9% | 0.4% | 0 | 43 312 453 | 19.6% | 1.1% | 0 | 21.7% |
| YTD | 1 347 378 | 8.6% | 0.7% | 0 | 569 045 768 | 20.6% | 1.9% | 0.1 | 3.5% |
| MAT | 1 945 364 | 9.7% | 0.7% | 0 | 798 334 396 | 19.7% | 2.0% | 0.1 | 2.1% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 64 571 | -7.8% | 43.9% | -1.2 | 34 201 085 | -8.1% | 49.3% | -1.6 | -5.3% |
| MoM | 281 557 | 10.8% | 46.3% | -0.4 | 148 737 462 | 10.9% | 52.0% | -0.6 | 11.7% |
| YTD | 3 573 956 | -6.4% | 56.1% | -10.2 | 1 815 938 107 | 4.9% | 61.6% | -8.8 | 10.7% |
| MAT | 5 038 006 | -0.6% | 58.4% | -7.6 | 2 509 475 402 | 11.5% | 63.8% | -6.3 | 12.3% |
| ESPUMISAN BABY | |||||||||
| WoW | 27 369 | -4.5% | 33.8% | 0.4 | 17 986 067 | -5.0% | 47.4% | 0.2 | -5.6% |
| MoM | 112 687 | 10.3% | 33.4% | -0.9 | 73 791 527 | 12.4% | 47.1% | -0.1 | 13.3% |
| YTD | 1 126 111 | -9.9% | 37.8% | -4 | 701 626 165 | -3.4% | 51.2% | -5.4 | -0.3% |
| MAT | 1 540 244 | -10.6% | 38.4% | -3.3 | 946 819 857 | -3.0% | 52.0% | -3.8 | -2.9% |
| FASTUM | |||||||||
| WoW | 18 238 | -24.1% | 0.9% | -0.2 | 10 071 982 | -20.7% | 2.2% | -0.4 | -5.2% |
| MoM | 77 456 | 19.6% | 0.9% | 0 | 42 173 280 | 18.5% | 2.2% | 0.1 | 15.2% |
| YTD | 840 153 | -20.1% | 1.2% | -0.3 | 432 507 053 | -10.5% | 2.6% | -0.6 | 2.0% |
| MAT | 1 173 581 | -18.8% | 1.2% | -0.3 | 589 639 632 | -9.9% | 2.7% | -0.5 | 1.3% |
| IODOMARIN | |||||||||
| WoW | 121 628 | 56.6% | 28.0% | 4.7 | 22 333 932 | 56.6% | 14.2% | 4.3 | 30.1% |
| MoM | 335 689 | 32.6% | 24.3% | 2.3 | 62 171 772 | 28.4% | 10.7% | 1 | 20.3% |
| YTD | 2 370 425 | 7.8% | 19.8% | 0.2 | 469 581 339 | 13.5% | 8.9% | 0 | 6.8% |
| MAT | 3 337 279 | 26.0% | 20.7% | 2.9 | 648 327 671 | 27.5% | 9.4% | 1.2 | 8.2% |
| LIOTON | |||||||||
| WoW | 18 807 | -10.4% | 1.8% | -0.1 | 20 552 914 | -9.5% | 3.7% | -0.1 | -7.0% |
| MoM | 83 625 | -9.1% | 1.8% | -0.2 | 90 280 193 | -8.4% | 3.9% | -0.4 | 1.3% |
| YTD | 1 047 120 | -21.4% | 2.4% | -0.5 | 1 071 774 257 | -1.4% | 4.7% | -0.9 | -6.0% |
| MAT | 1 407 168 | -18.1% | 2.4% | -0.4 | 1 387 779 116 | 0.7% | 4.9% | -0.7 | -6.0% |
| MEZYM | |||||||||
| WoW | 247 358 | 0.7% | 18.5% | 0.5 | 37 605 395 | 2.2% | 13.1% | 0.7 | -2.1% |
| MoM | 1 012 478 | 8.5% | 18.9% | -0.8 | 154 387 022 | 9.1% | 13.4% | -0.5 | 13.2% |
| YTD | 14 486 959 | 1.3% | 27.4% | -0.3 | 2 216 024 663 | 10.5% | 19.6% | -1.1 | 2.2% |
| MAT | 20 945 157 | 9.0% | 28.9% | 1.2 | 3 119 550 582 | 16.0% | 20.8% | 0 | 4.4% |
| MIG 400 | |||||||||
| WoW | 172 335 | -3.2% | 2.8% | 0 | 20 676 973 | -2.1% | 2.3% | 0.1 | -2.5% |
| MoM | 705 306 | 16.2% | 2.8% | -0.1 | 83 916 288 | 16.1% | 2.2% | 0 | 21.7% |
| YTD | 6 637 370 | -9.3% | 3.4% | -0.5 | 780 547 272 | -5.3% | 2.6% | -0.5 | 3.5% |
| MAT | 9 208 133 | -3.0% | 3.4% | -0.2 | 1 072 763 706 | 1.1% | 2.7% | -0.3 | 2.1% |
| PROSTAMOL | |||||||||
| WoW | 25 928 | -9.0% | 14.6% | -0.5 | 36 234 560 | -9.6% | 15.7% | -0.7 | -5.7% |
| MoM | 107 142 | 27.2% | 15.1% | 0 | 149 162 441 | 25.9% | 16.1% | 0.2 | 27.1% |
| YTD | 1 241 759 | -21.8% | 19.4% | -5.7 | 1 742 070 023 | -12.5% | 20.7% | -6.7 | 1.0% |
| MAT | 1 793 122 | -16.0% | 20.5% | -4.2 | 2 452 169 373 | -7.7% | 21.8% | -5.1 | 1.2% |
| RESPERO MYRTOL | |||||||||
| WoW | 28 494 | -15.0% | 7.6% | -0.2 | 13 719 830 | -14.1% | 8.0% | -0.1 | -12.7% |
| MoM | 111 511 | 68.8% | 7.7% | -1.4 | 53 402 083 | 71.8% | 8.0% | -1.2 | 99.0% |
| YTD | 939 073 | 146.6% | 8.9% | 5 | 439 237 586 | 143.2% | 8.7% | 4.5 | 6.1% |
| MAT | 1 305 146 | 129.6% | 8.5% | 4.5 | 603 538 421 | 122.1% | 8.4% | 3.8 | 8.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 7 729 546 | -6.0% | 5.5% | -0.6 | 1 533 868 436 | 10.9% | 5.2% | -0.2 | 4.9% |
| DEXALGIN | 1 347 378 | 8.6% | 0.7% | 0 | 569 045 768 | 20.6% | 1.9% | 0.1 | 3.5% |
| ESPUMISAN (ADULTS) | 3 573 956 | -6.4% | 56.1% | -10.2 | 1 815 938 107 | 4.9% | 61.6% | -8.8 | 10.7% |
| ESPUMISAN BABY | 1 126 111 | -9.9% | 37.8% | -4 | 701 626 165 | -3.4% | 51.2% | -5.4 | -0.3% |
| FASTUM | 840 153 | -20.1% | 1.2% | -0.3 | 432 507 053 | -10.5% | 2.6% | -0.6 | 2.0% |
| IODOMARIN | 2 370 425 | 7.8% | 19.8% | 0.2 | 469 581 339 | 13.5% | 8.9% | 0 | 6.8% |
| LIOTON | 1 047 120 | -21.4% | 2.4% | -0.5 | 1 071 774 257 | -1.4% | 4.7% | -0.9 | -6.0% |
| MEZYM | 14 486 959 | 1.3% | 27.4% | -0.3 | 2 216 024 663 | 10.5% | 19.6% | -1.1 | 2.2% |
| MIG 400 | 6 637 370 | -9.3% | 3.4% | -0.5 | 780 547 272 | -5.3% | 2.6% | -0.5 | 3.5% |
| PROSTAMOL | 1 241 759 | -21.8% | 19.4% | -5.7 | 1 742 070 023 | -12.5% | 20.7% | -6.7 | 1.0% |
| RESPERO MYRTOL | 939 073 | 146.6% | 8.9% | 5 | 439 237 586 | 143.2% | 8.7% | 4.5 | 6.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 12 779 716 | 15.3% | 6.0% | 0.5 | 2 441 157 988 | 34.0% | 5.6% | 0.7 | 5.3% |
| DEXALGIN | 1 945 364 | 9.7% | 0.7% | 0 | 798 334 396 | 19.7% | 2.0% | 0.1 | 2.1% |
| ESPUMISAN (ADULTS) | 5 038 006 | -0.6% | 58.4% | -7.6 | 2 509 475 402 | 11.5% | 63.8% | -6.3 | 12.3% |
| ESPUMISAN BABY | 1 540 244 | -10.6% | 38.4% | -3.3 | 946 819 857 | -3.0% | 52.0% | -3.8 | -2.9% |
| FASTUM | 1 173 581 | -18.8% | 1.2% | -0.3 | 589 639 632 | -9.9% | 2.7% | -0.5 | 1.3% |
| IODOMARIN | 3 337 279 | 26.0% | 20.7% | 2.9 | 648 327 671 | 27.5% | 9.4% | 1.2 | 8.2% |
| LIOTON | 1 407 168 | -18.1% | 2.4% | -0.4 | 1 387 779 116 | 0.7% | 4.9% | -0.7 | -6.0% |
| MEZYM | 20 945 157 | 9.0% | 28.9% | 1.2 | 3 119 550 582 | 16.0% | 20.8% | 0 | 4.4% |
| MIG 400 | 9 208 133 | -3.0% | 3.4% | -0.2 | 1 072 763 706 | 1.1% | 2.7% | -0.3 | 2.1% |
| PROSTAMOL | 1 793 122 | -16.0% | 20.5% | -4.2 | 2 452 169 373 | -7.7% | 21.8% | -5.1 | 1.2% |
| RESPERO MYRTOL | 1 305 146 | 129.6% | 8.5% | 4.5 | 603 538 421 | 122.1% | 8.4% | 3.8 | 8.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 190 506 | -8.5% | 3.7% | -0.1 | 39 791 466 | -8.8% | 3.7% | -0.1 | -6.8% |
| DEXALGIN | 22 754 | -15.7% | 0.4% | -0.1 | 10 944 063 | -15.8% | 1.2% | -0.1 | -2.5% |
| ESPUMISAN (ADULTS) | 64 571 | -7.8% | 43.9% | -1.2 | 34 201 085 | -8.1% | 49.3% | -1.6 | -5.3% |
| ESPUMISAN BABY | 27 369 | -4.5% | 33.8% | 0.4 | 17 986 067 | -5.0% | 47.4% | 0.2 | -5.6% |
| FASTUM | 18 238 | -24.1% | 0.9% | -0.2 | 10 071 982 | -20.7% | 2.2% | -0.4 | -5.2% |
| IODOMARIN | 121 628 | 56.6% | 28.0% | 4.7 | 22 333 932 | 56.6% | 14.2% | 4.3 | 30.1% |
| LIOTON | 18 807 | -10.4% | 1.8% | -0.1 | 20 552 914 | -9.5% | 3.7% | -0.1 | -7.0% |
| MEZYM | 247 358 | 0.7% | 18.5% | 0.5 | 37 605 395 | 2.2% | 13.1% | 0.7 | -2.1% |
| MIG 400 | 172 335 | -3.2% | 2.8% | 0 | 20 676 973 | -2.1% | 2.3% | 0.1 | -2.5% |
| PROSTAMOL | 25 928 | -9.0% | 14.6% | -0.5 | 36 234 560 | -9.6% | 15.7% | -0.7 | -5.7% |
| RESPERO MYRTOL | 28 494 | -15.0% | 7.6% | -0.2 | 13 719 830 | -14.1% | 8.0% | -0.1 | -12.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 747 528 | 79.1% | 3.7% | 0 | 153 590 034 | 85.1% | 3.8% | 0.1 | 81.0% |
| DEXALGIN | 90 811 | 16.9% | 0.4% | 0 | 43 312 453 | 19.6% | 1.1% | 0 | 21.7% |
| ESPUMISAN (ADULTS) | 281 557 | 10.8% | 46.3% | -0.4 | 148 737 462 | 10.9% | 52.0% | -0.6 | 11.7% |
| ESPUMISAN BABY | 112 687 | 10.3% | 33.4% | -0.9 | 73 791 527 | 12.4% | 47.1% | -0.1 | 13.3% |
| FASTUM | 77 456 | 19.6% | 0.9% | 0 | 42 173 280 | 18.5% | 2.2% | 0.1 | 15.2% |
| IODOMARIN | 335 689 | 32.6% | 24.3% | 2.3 | 62 171 772 | 28.4% | 10.7% | 1 | 20.3% |
| LIOTON | 83 625 | -9.1% | 1.8% | -0.2 | 90 280 193 | -8.4% | 3.9% | -0.4 | 1.3% |
| MEZYM | 1 012 478 | 8.5% | 18.9% | -0.8 | 154 387 022 | 9.1% | 13.4% | -0.5 | 13.2% |
| MIG 400 | 705 306 | 16.2% | 2.8% | -0.1 | 83 916 288 | 16.1% | 2.2% | 0 | 21.7% |
| PROSTAMOL | 107 142 | 27.2% | 15.1% | 0 | 149 162 441 | 25.9% | 16.1% | 0.2 | 27.1% |
| RESPERO MYRTOL | 111 511 | 68.8% | 7.7% | -1.4 | 53 402 083 | 71.8% | 8.0% | -1.2 | 99.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs